Daniel Václavík

ORCID: 0000-0002-1902-1093
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Stroke Rehabilitation and Recovery
  • Cerebrovascular and Carotid Artery Diseases
  • Venous Thromboembolism Diagnosis and Management
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Peripheral Artery Disease Management
  • Neurological Disorders and Treatments
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiovascular Health and Disease Prevention
  • Trauma and Emergency Care Studies
  • Cardiovascular Syncope and Autonomic Disorders
  • Intracranial Aneurysms: Treatment and Complications
  • Dysphagia Assessment and Management
  • Tracheal and airway disorders
  • Multiple Sclerosis Research Studies
  • Cardiac Imaging and Diagnostics
  • Coronary Interventions and Diagnostics
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Neurological Disease Mechanisms and Treatments
  • Esophageal and GI Pathology
  • Climate Change and Health Impacts
  • Cellular transport and secretion
  • Blood Pressure and Hypertension Studies
  • Sympathectomy and Hyperhidrosis Treatments
  • Long-Term Effects of COVID-19

University of Ostrava
2018-2025

Městská Nemocnice Ostrava
2025

University Hospital Hradec Králové
2023-2024

University of Calgary
2020-2024

Vitkovice - Research and Development (Czechia)
2008-2024

Charles University
2015-2024

Bayer (Germany)
2024

University Hospital Ostrava
2022-2023

University of Hradec Králové
2022

Hospital de Clínicas de Porto Alegre
2021

David H. Miller Robert J. Fox J. Theodore Phillips Michael Hutchinson Eva Havrdová and 95 more Mariko Kita Claudia A. M. Gandini Wheeler‐Kingshott Daniel J. Tozer David MacManus Tarek Yousry Mary Goodsell Minhua Yang Ray Zhang Vissia Viglietta Katherine Dawson Robert J. Fox J. Theodore Phillips Michael Hutchinson Eva Havrdová Mariko Kita Kate Wilson Minhua Yang Katherine Dawson Jack P. Antel James S. Ware Chris H. Polman Peter R. Kowey Raymond Chung George L. Bakris John R. Richert Burt Seibert David Brandes David Brassat Bruce A. Cohen Ricarda Diem Myla Goldman Robert Herndon Aaron Miller Hayrettin Tumani Teresa Alfaro-Vidal Carolina Lage Crespo Jo Foster K.R. Hunter Almudena Garcia-Gomez David MacManus David Miller Virginia Santana Dan Tozer Claudia A. M. Gandini Wheeler‐Kingshott Tarek Yousry Christopher Kneebone Aliaksandr Fedulau С А Лихачев Elena Mikhailova Halina Naumova D. Decoo Luc Vande Gaer Christian Sindic Sanja Grgić Osman Sinanović Enra Suljić Надежда Делева Dimitar Georgiev Lyubomir Haralanov Sonyia Ivanova I Manchev Dimitar Minchev P. Stamenova Ivailo Tournev Elena Vacheva Zahari Zahariev Amit Bar-Or Gregg Blevins Marcelo Kremenchutzky Felix Veloso Norbert Witt Roberto Vargas Howell Alexander Parajeles Vindas Mario Habek Josip Rudež Silva Soldo-Butković Ranka Baraba Vurdelja David Doležil Eva Havrdová Jiří Nova'k Daniel Václavík Katrin Antsov Katrin Gross‐Paju Sulev Haldre Alla Palu Toomas Toomsoo Abdullatif Al Khedr William Camu Marc Debouverie Gilles Defer de Sèze Pierre Labauge Thibault Moreau Jean Pelletier L. Rumbach

<h3>Objective:</h3> To evaluate the effects of oral delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) on MRI lesion activity and load, atrophy, magnetization transfer ratio (MTR) measures from Comparator an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis (CONFIRM) study. <h3>Methods:</h3> CONFIRM was a 2-year, placebo-controlled study efficacy safety DMF 240 mg twice (BID) or 3 times daily (TID) 1,417 patients with relapsing-remitting multiple sclerosis...

10.1212/wnl.0000000000001360 article EN cc-by-nc-nd Neurology 2015-02-14

Stroke treatment is time-dependent, yet no study has systematically examined response to individual stroke symptoms in the general population. This nationwide identifies which specific factors prompt correct (calling 911) stroke.Between November and December of 2005, a survey using 3-stage random-sampling method including area, household, household member sampling was conducted throughout Czech Republic. Participants >40 years old were personally interviewed via structured standardized...

10.1161/strokeaha.107.499806 article EN Stroke 2008-04-25

Little is known about the effect of thrombolysis in patients with preexisting disability. Our aim was to evaluate impact different levels prestroke disability on patients' profile and outcome after intravenous thrombolysis.We analyzed data all stroke admitted between October 2003 December 2011 that were contributed Safe Implementation Treatments Stroke-Eastern Europe (SITS-EAST) registry. Patients no at (modified Rankin Scale [mRS] score, 0) used as a reference multivariable logistic...

10.1161/strokeaha.113.003744 article EN Stroke 2014-02-05

10.1016/s0140-6736(19)31192-4 article EN The Lancet 2019-05-24

To undertake an effectiveness and safety analysis of EVT in patients with LVO NIH Stroke Scale (NIHSS) score ≤6 using datasets multicenter multinational nature.We pooled anterior circulation occlusion from 3 prospective international cohorts. Patients were eligible if presentation occurred within 12 hours last known well baseline NIHSS ≤6. Primary outcome was modified Rankin (mRS) 0-1 at 90 days. Secondary outcomes included neurologic deterioration 24 (change ≥2 points), mRS 0-2 days, 90-day...

10.1212/wnl.0000000000010955 article EN Neurology 2020-09-29

Background: Acute stroke lesions become more hypodense on non-contrast CT as the ischemic injury matures. Lesions transition to established infarcts at which time recanalization treatment is thought be futile, if not harmful. As it possible directly quantify degree of progression, eligibility for determined using temporal criteria. In this study we used an AI approach segment and hypoattenuation acute baseline CTs, explored its impact clinical outcome following mechanical thrombectomy....

10.1161/str.56.suppl_1.67 article EN Stroke 2025-01-30

Follow-up infarct volume (FIV) is a proposed surrogate endpoint for proof-of-concept clinical studies in acute ischemic stroke (AIS). This study aimed to provide validation of an automated FIV algorithm, demonstrating the association imaging biomarkers with outcomes support use these endpoints trials. Data were gathered adult AIS patients undergoing mechanical thrombectomy follow-up 12-96 h from initial assessment. Non-contrast computed tomography was used quantify volume. Image processing...

10.3389/fneur.2025.1483138 article EN cc-by Frontiers in Neurology 2025-03-19

Abstract Background and Purpose Mechanical thrombectomy ( MT ) is indicated for the treatment of large vessel occlusion LVO stroke. should be provided as quickly possible; therefore, a test identifying suspected in prehospitalization stage needed to ensure direct transport comprehensive stroke center CSC ). We assume that patients with clinically severe hemiparesis have high probability modified FAST into PLUS test: The first part second evaluates presence arm or leg motor deficit. This...

10.1002/brb3.1087 article EN cc-by Brain and Behavior 2018-08-07

Knowledge of the implementation gap would facilitate use intravenous thrombolysis in stroke, which is still low many countries. The study was conducted to identify national targets for utilisation and logistics thrombolysis.Multicomponent interventions by stakeholders health care optimise prehospital hospital management with goal fast accessible every candidate. Implementation results were documented from prospectively collected cases all 45 stroke centres nationally. thrombolytic rate...

10.1177/23969873211007684 article EN European Stroke Journal 2021-04-12

According to the European license, alteplase can be given no sooner than 3 months after previous stroke. However, it is not known whether past history of stroke influences effect treatment. Our aim was evaluate safety and functional outcome intravenous thrombolysis administered in everyday practice patients with stroke≤3 compared those first-ever stroke.We analyzed consecutive cases treated between October 2003 July 2014 contributed Safe Implementation Thrombolysis for Stroke-Eastern Europe...

10.1161/strokeaha.115.010420 article EN Stroke 2015-10-09

Cardioembolic stroke (CS) in patients without thrombolytic treatment is associated with a worse clinical outcome and higher mortality compared to other types of stroke. The aim this study was determine the CS treated by intravenous thrombolysis (IVT).Data from SITS-EAST register (Safe Implementation Treatments Stroke) were analyzed who received IVT 2000 April 2014. effect etiology according ICD-10 classification on using univariate multivariate analysis. outcomes assessed as follows:...

10.1111/ane.12880 article EN Acta Neurologica Scandinavica 2017-12-08

This article describes policy processes that have led to the re-organisation of stroke care in Czech Republic since 2011, which has been part a broader process concentration several medical fields. Currently, is provided by 13 Comprehensive and 32 Primary Stroke Centres. The paper explains factors supported reform implementation, reviews implications, discusses future challenges. Mandatory reporting quality indicators, introduction benchmarking system, integration with pre-hospital emergency...

10.1016/j.healthpol.2021.01.011 article EN other-oa Health Policy 2021-01-30

Background and aims Fabry disease (FD) is a rare X-linked lysosomal storage disorder caused by disease-associated variants in the alpha-galactosidase A gene ( GLA ). FD known cause of stroke younger patients. There are limited data on prevalence risk unselected Methods prospective nationwide study including 35 (78%) all 45 centers consecutive patients admitted during three months. Clinical were collected RES-Q database. was diagnosed using dried blood spots stepwise manner: males—enzymatic...

10.1371/journal.pone.0260601 article EN cc-by PLoS ONE 2021-12-14
Philippa C. Lavallée Hubert Charles Gregory W. Albers Louis R. Caplan Geoffrey A. Donnan and 95 more José M. Ferro Michael G. Hennerici Julien Labreuche Carlos A. Molina Peter M. Rothwell Philippe Gabríel Steg Pierre‐Jean Touboul Shinichiro Uchiyama Éric Vicaut Ka Sing Wong Pierre Amarenco Sebastián Ameriso Claudia Nora Gandolfo Guillermo Povedano Javier Sagesse H Gervas Pavón Jorge Cancino W P Toledo Yinin Huang Xiping Gong Y. Peñasco Martín Donghu Mi Tian Song Yilong Wang Yongjun Wang Fran Chandgfend Guo Contago Jiao Hongyun Heman Intao Wu Jixing Song Liquing Tai Liwen Ran Liu Shujuan Tian Wenhong Liu Tak Hong Soi Ka Sing Wong L. Barnaby Roxanna Roman Flasar Bedriska Ziktova Michael Reif Daniel Sanak Goldemund Jiří Neumann Dagmar Svakov Daniel Šaňák Michael Kral David Školoudík Daniel Václavík Martin Kuhila Pierre Amarenco Lucie Cabrejo Céline Guidoux Cristina Hobeanu Philippa C. Lavallée Elena Meseguer Henrich Audebert Daniel Menger W. Heide S. Lipp Huriye Ozalp Christine Sctzmann Christian Weimar Katharina Platzbecker Peter A. Ringleb Michel G Hennerici Martin Griebe Katrin Knoll Olaf Olaf Willmann Juergen Faiss Susan Dilan Anja Kobersteein Katarina Krimmer Sandra Tietz Peter Wienecke Gerhard F. Hamann Nico Burkhardt Martin Liebetrau Nadine Mueller Michaela Wagner Dr Strivastava Peter J. Kelly Hashomer David Tanne Milena Cavazzuti Sabrina Anticoli Danilo Toni Ken Nagata Yasushi Okada Hiroshi Yamagami Kazuo Minematsu Jojo Nakagawara Shinchiro Uchiyama Byung Chui Lee Byung Woo Yoon J. K. E. Hoe Jong Moo Park

The coexistence of underlying causes in patients with transient ischemic attack (TIA) or minor stroke as well their associated 5-year risks are not known.

10.1001/jamaneurol.2023.3344 article EN JAMA Neurology 2023-10-02

Background and Purpose: Ischemic stroke is a leading cause of mortality morbidity worldwide. The time from onset to treatment impacts clinical outcome. Here, we examined whether changing triage model “drip ship” “mothership” yielded significant reductions onset-to-groin (OGT) in patients receiving EVT onset-to-needle (ONT) IVT-treated patients, compared before FAST-PLUS test implementation. We also investigated the new improved outcomes. Methods: In before/after multicenter study, evaluated...

10.3389/fneur.2021.676126 article EN cc-by Frontiers in Neurology 2021-06-11

Background The benefit of intravenous thrombolysis is time dependent. It remains unclear, however, whether dramatic shortening door-to-needle (DNT) among different types hospitals nationwide does not compromise safety and still improves outcome. Methods Results Multifaceted intervention to shorten DNT was introduced at a national level, prospectively collected data from registry between 2004 2019 were analyzed. Generalized estimating equation used identify the association outcomes...

10.1161/jaha.121.023524 article EN cc-by-nc-nd Journal of the American Heart Association 2022-05-16

The safety and efficacy of intravenous thrombolysis (IVT) are well established in anterior circulation stroke (ACS) but much less clear for posterior (PCS). aim this study was to evaluate the occurrence parenchymal hematoma (PH) 3-month clinical outcomes after IVT PCS ACS. In an observational, cohort multicenter study, we analyzed data from ischemic patients treated with prospectively collected SITS (Safe Implementation Treatments Stroke) registry Czech Republic between 2004 2018. Out 10,211...

10.3390/biomedicines12020404 article EN cc-by Biomedicines 2024-02-09

Background and aim In-stent restenosis (ISR) belongs to an infrequent but potentially serious complication after carotid angioplasty stenting in patients with severe stenosis. Some of these might be contraindicated repeat percutaneous transluminal or without (rePTA/S). The purpose the study is compare safety effectiveness endarterectomy stent removal (CEASR) rePTA/S ISR. Methods Consecutive ISR (≥80%) were randomly allocated CEASR group. incidence intervention, stroke, transient ischaemic...

10.1136/svn-2022-002075 article EN cc-by-nc Stroke and Vascular Neurology 2023-03-27
Coming Soon ...